S2Medical AB (S2M) — Cash Flow Reinvestment Rate
Latest as of December 2025:
2.99x
S2Medical AB (S2M) has a Cash Flow Reinvestment Rate of 2.99x as of December 2025, reinvesting Skr2.02 Million (capex Skr2.02 Million ) from operating cash flow of Skr676.00K. Explore reinvestment intensity of S2Medical AB to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
2.99x
(Capex + Investments) / Operating CF
Total Reinvested
Skr2.02 Million
Capex + Investments
Operating Cash Flow
Skr676.00K
SEK
Capital Expenditures
Skr2.02 Million
SEK
S2Medical AB Cash Flow Reinvestment Rate (2024–2025)
Historical reinvestment intensity for S2Medical AB across 2 annual periods. Also explore balance sheet size of S2Medical AB for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for S2Medical AB (2024–2025)
Year-by-year capital reinvestment analysis for S2Medical AB. For live market cap and broader valuation context, see S2M stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.00x | Skr675.00K | Skr675.00K | Skr675.00K | ▲ +296.8% |
| 2024 | 0.25x | Skr1.27 Million | Skr5.03 Million | Skr634.00K | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow